프로바이오틱스 시장 규모, 점유율, 성장 및 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of probiotics Market

The global probiotics market was valued at USD 73.13 billion in 2025 and is projected to grow from USD 77.40 billion in 2026 to USD 134.50 billion by 2034, exhibiting a CAGR of 7.15% during 2026-2034. Asia Pacific dominated the market with a 48.35% share in 2025, supported by rising disposable incomes, expanding middle-class populations, and growing consumption of probiotic-enriched foods and beverages.

Probiotics are live microorganisms incorporated into food, beverages, dietary supplements, animal feed, and cosmetics to promote gut microbiota balance and overall health. Increasing consumer awareness regarding digestive health, immunity, and preventive healthcare is significantly accelerating global demand.

Market Dynamics

Market Drivers

Shift Toward Functional Food and Beverages

Consumers are increasingly transitioning from traditional food products to functional foods enriched with probiotics. Dairy-free, plant-based, and targeted probiotic formulations are gaining strong traction. Manufacturers are introducing strain-specific products designed to address digestive disorders, immunity enhancement, and overall wellness. Continuous innovation in microbiome-based solutions is further strengthening market growth.

Market Restraints

High Production Costs and Premium Pricing

The manufacturing of probiotic strains requires specialized infrastructure, advanced fermentation technologies, and clinical validation. This results in higher production costs, leading to premium pricing of probiotic-enriched products. Price sensitivity in developing economies may restrict adoption, particularly among middle- and lower-income consumers.

Market Opportunities

Expansion of E-Commerce Platforms

Rapid growth in online retail channels is enhancing accessibility of probiotic products globally. Direct-to-consumer sales, personalized subscription models, and targeted digital marketing campaigns are enabling manufacturers to expand their customer base. Rising internet penetration and convenience-driven shopping behavior are creating strong growth opportunities.

Market Trends

Personalized Nutrition and Advanced Formulations

Personalized probiotic solutions tailored to individual microbiome profiles are emerging as a key industry trend. Companies are leveraging advanced biotechnology and microbiome research to develop customized dietary supplements and functional beverages. Clean-label products with reduced sugar and simplified ingredients are also gaining popularity among health-conscious consumers.

Segmentation Analysis

By Source

The market is segmented into bacteria, yeast, and others.

• The bacteria segment is expected to dominate with 86.77% share in 2026, driven by clinically validated strains such as Lactobacillus and Bifidobacterium. These strains are widely used in yogurt and supplements for digestive and immune health benefits.
• The yeast segment is projected to grow at a CAGR of 6.06%, supported by its stability and complementary health benefits.

By Product Type

The market is segmented into food & beverages, supplements, animal feed, and cosmetics.

• Food & beverages are projected to dominate with a 61.76% share in 2026, driven by demand for dairy-based probiotic drinks, functional cereals, and non-dairy beverages.
• Supplements are expected to grow at a CAGR of 6.30%, supported by increasing demand for targeted health solutions and customized nutrition.
• Expanding use in animal feed is further diversifying applications.

By End Use

• The human segment holds the largest share at 94.81% in 2026, driven by rising preventive healthcare awareness.
• The animal segment is projected to grow at a CAGR of 5.59%, supported by increasing use in livestock, aquaculture, and pet nutrition.

By Form

• Liquid probiotics account for 53.54% share in 2026, owing to higher bioavailability and faster absorption.
• Powder form is projected to grow at a 6.90% CAGR, driven by longer shelf life and suitability for supplements and infant formula.

By Distribution Channel

• Supermarkets & hypermarkets hold the largest share due to brand visibility and wide product availability.
• Online retail/e-commerce is the fastest-growing channel, projected to grow at a CAGR of 7.47%, driven by convenience and expanding digital infrastructure.

Regional Outlook

Asia Pacific

Asia Pacific reached USD 35.36 billion in 2025, maintaining its dominant position. China and Japan are key contributors, with projected 2026 valuations of USD 14.08 billion and USD 8.30 billion, respectively. India is also emerging rapidly due to expanding middle-class demand.

Europe

Europe is valued at USD 13.21 billion in 2025 and remains the second-largest region. The region is projected to grow at a CAGR of 6.23%, supported by strong demand for fermented dairy products and gut health supplements.

North America

North America is estimated at USD 9.92 billion in 2025, with the U.S. market projected to reach USD 10.50 billion in 2026. High awareness of gut health and preventive wellness supports demand.

South America & Middle East & Africa

South America recorded USD 6.80 billion in 2025, driven by rising adoption of functional foods. The Middle East & Africa region is expected to grow steadily, supported by increasing focus on nutrition and preventive healthcare.

Competitive Landscape

The market features established multinational players and biotechnology firms. Key companies include Yakult Honsha Co., Ltd., Danone S.A., Nestle S.A., Chr. Hansen Holding A/S, DuPont Nutrition & Biosciences, BioGaia AB, Probi AB, ADM, Kerry Group Plc, and Meiji Holdings Co., Ltd. Companies are focusing on product portfolio expansion, strain innovation, and research & development to maintain competitive advantage.

Conclusion

The global probiotics market is set to expand from USD 73.13 billion in 2025 to USD 134.50 billion by 2034, driven by rising consumer awareness of digestive health, preventive healthcare trends, and functional food demand. While high production costs pose challenges, expanding e-commerce channels, personalized nutrition solutions, and ongoing strain innovation will continue to propel market growth. With Asia Pacific leading and developed markets steadily expanding, the probiotics industry is positioned for sustainable and long-term expansion through 2034.

Segmentation By Source, Product Type, Form, End Use, Distribution Channel, and Region

By Product Type Food and Beverages

• Dairy-based products
• Non-dairy based beverages
• Cereals & snacks
• Baked food
• Frozen & confectionery
• Ready-to-eat packaged meals

Supplements

• Nutritional supplements
• Specialty supplements
• Infant formula

Animal Feed

Cosmetics

By Source Bacteria

• Lactobacillus
• Bifidobacterium
• Others

Yeast

Others

By Form * Powder

• Liquid
• Encapsulated
• Others

By End Use * Human

• Animal

By Distribution Channel * Supermarkets & Hypermarkets

• Pharmacies & Drug Stores
• Health & Specialty Stores
• Online Retail / E-commerce
• Others

By Geography North America (By Source, Product Type, Form, End Use, Distribution Channel , and Country)

• U.S. (By Form)
• Canada (By Form)
• Mexico (By Form)

Europe (By Source, Product Type, Form, End Use, Distribution Channel, and Country)

• Germany (By Form)
• U.K. (By Form)
• Spain (By Form)
• France (By Form)
• Italy (By Form)
• Rest of Europe (By Form)

Asia Pacific (By Source, Product Type, Form, End Use, Distribution Channel, and Country)

• China (By Form)
• India (By Form)
• Australia (By Form)
• Japan (By Form)
• Southeast Asia (By Form)
• Rest of the Asia Pacific (By Form)

South America (By Source, Product Type, Form, End Use, Distribution Channel , and Country)

• Brazil (By Form)
• Argentina (By Form)
• Rest of South America (By Form)

Middle East and Africa (By Source, Product Type, Form, End Use, Distribution Channel and Country)

• UAE (By Form)
• South Africa (By Form)

Rest of the Middle East & Africa (By Form)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Market Overview of Related/Parent Market
• 4.2. Supply Chain Analysis
• 4.3. Regulatory Analysis
• 4.4. Industry SWOT Analysis
• 4.5. Recent Industry Developments - Policies, Mergers & Acquisitions, and New Product Launches

5. Global Probiotics Market Analysis, Insights and Forecast, 2026-2034

• 5.1. Key Findings / Summary
• 5.2. Market Size Estimates and Forecast
  • 5.2.1. By Product Type (Value)
    • 5.2.1.1. Food and Beverages
      • 5.2.1.1.1. Dairy-based products
      • 5.2.1.1.2. Non-dairy based beverages
      • 5.2.1.1.3. Cereals & snacks
      • 5.2.1.1.4. Baked food
      • 5.2.1.1.5. Frozen & confectionery
      • 5.2.1.1.6. Ready-to-eat packaged meals
    • 5.2.1.2. Supplements
      • 5.2.1.2.1. Nutritional supplements
      • 5.2.1.2.2. Specialty supplements
      • 5.2.1.2.3. Infant formula
    • 5.2.1.3. Animal Feed
    • 5.2.1.4. Cosmetics
  • 5.2.2. By Source (Value)
    • 5.2.2.1. Bacteria
      • 5.2.2.1.1. Lactobacillus
      • 5.2.2.1.2. Bifidobacterium
      • 5.2.2.1.3. Others
    • 5.2.2.2. Yeast
    • 5.2.2.3. Others
  • 5.2.3. By Form (Value)
    • 5.2.3.1. Powder
      • 5.2.3.1.1. Liquid
      • 5.2.3.1.2. Encapsulated
      • 5.2.3.1.3. Others
  • 5.2.4. By End Use (Value)
    • 5.2.4.1. Human
      • 5.2.4.1.1. Animal
  • 5.2.5. By Distribution Channel (Value)
    • 5.2.5.1. Supermarkets & Hypermarkets
      • 5.2.5.1.1. Pharmacies & Drug Stores
      • 5.2.5.1.2. Health & Specialty Stores
      • 5.2.5.1.3. Online Retail / E-commerce
      • 5.2.5.1.4. Others
  • 5.2.6. By Region (Value)
    • 5.2.6.1. North America
    • 5.2.6.2. Europe
    • 5.2.6.3. Asia Pacific
    • 5.2.6.4. South America
    • 5.2.6.5. Middle East & Africa

6. North America Probiotics Market Analysis, Insights and Forecast, 2026-2034

• 6.1. Key Findings / Summary
• 6.2. Market Size Estimates and Forecast
  • 6.2.1. By Product Type (Value)
    • 6.2.1.1. Food and Beverages
      • 6.2.1.1.1. Dairy-based products
      • 6.2.1.1.2. Non-dairy based beverages
      • 6.2.1.1.3. Cereals & snacks
      • 6.2.1.1.4. Baked food
      • 6.2.1.1.5. Frozen & confectionery
      • 6.2.1.1.6. Ready-to-eat packaged meals
    • 6.2.1.2. Supplements
      • 6.2.1.2.1. Nutritional supplements
      • 6.2.1.2.2. Specialty supplements
      • 6.2.1.2.3. Infant formula
    • 6.2.1.3. Animal Feed
    • 6.2.1.4. Cosmetics
  • 6.2.2. By Source (Value)
    • 6.2.2.1. Bacteria
      • 6.2.2.1.1. Lactobacillus
      • 6.2.2.1.2. Bifidobacterium
      • 6.2.2.1.3. Others
    • 6.2.2.2. Yeast
    • 6.2.2.3. Others
  • 6.2.3. By Form (Value)
    • 6.2.3.1. Powder
      • 6.2.3.1.1. Liquid
      • 6.2.3.1.2. Encapsulated
      • 6.2.3.1.3. Others
  • 6.2.4. By End Use (Value)
    • 6.2.4.1. Human
      • 6.2.4.1.1. Animal
  • 6.2.5. By Distribution Channel (Value)
    • 6.2.5.1. Supermarkets & Hypermarkets
      • 6.2.5.1.1. Pharmacies & Drug Stores
      • 6.2.5.1.2. Health & Specialty Stores
      • 6.2.5.1.3. Online Retail / E-commerce
      • 6.2.5.1.4. Others
  • 6.2.6. By Country
    • 6.2.6.1. U.S.
      • 6.2.6.1.1. By Form (Value)
        • 6.2.6.1.1.1. Powder
        • 6.2.6.1.1.2. Liquid
        • 6.2.6.1.1.3. Encapsulated
        • 6.2.6.1.1.4. Others
    • 6.2.6.2. Canada
      • 6.2.6.2.1. By Form (Value)
        • 6.2.6.2.1.1. Powder
        • 6.2.6.2.1.2. Liquid
        • 6.2.6.2.1.3. Encapsulated
        • 6.2.6.2.1.4. Others
    • 6.2.6.3. Mexico
      • 6.2.6.3.1. By Form (Value)
        • 6.2.6.3.1.1. Powder
        • 6.2.6.3.1.2. Liquid
        • 6.2.6.3.1.3. Encapsulated
        • 6.2.6.3.1.4. Others

7. Europe Probiotics Market Analysis, Insights and Forecast, 2026-2034

• 7.1. Key Findings / Summary
• 7.2. Market Size Estimates and Forecast
  • 7.2.1. By Product Type (Value)
    • 7.2.1.1. Food and Beverages
      • 7.2.1.1.1. Dairy-based products
      • 7.2.1.1.2. Non-dairy based beverages
      • 7.2.1.1.3. Cereals & snacks
      • 7.2.1.1.4. Baked food
      • 7.2.1.1.5. Frozen & confectionery
      • 7.2.1.1.6. Ready-to-eat packaged meals
    • 7.2.1.2. Supplements
      • 7.2.1.2.1. Nutritional supplements
      • 7.2.1.2.2. Specialty supplements
      • 7.2.1.2.3. Infant formula
    • 7.2.1.3. Animal Feed
    • 7.2.1.4. Cosmetics
  • 7.2.2. By Source (Value)
    • 7.2.2.1. Bacteria
      • 7.2.2.1.1. Lactobacillus
      • 7.2.2.1.2. Bifidobacterium
      • 7.2.2.1.3. Others
    • 7.2.2.2. Yeast
    • 7.2.2.3. Others
  • 7.2.3. By Form (Value)
    • 7.2.3.1. Powder
      • 7.2.3.1.1. Liquid
      • 7.2.3.1.2. Encapsulated
      • 7.2.3.1.3. Others
  • 7.2.4. By End Use (Value)
    • 7.2.4.1. Human
      • 7.2.4.1.1. Animal
  • 7.2.5. By Distribution Channel (Value)
    • 7.2.5.1. Supermarkets & Hypermarkets
      • 7.2.5.1.1. Pharmacies & Drug Stores
      • 7.2.5.1.2. Health & Specialty Stores
      • 7.2.5.1.3. Online Retail / E-commerce
      • 7.2.5.1.4. Others
  • 7.2.6. By Country
    • 7.2.6.1. Germany
      • 7.2.6.1.1. By Form (Value)
        • 7.2.6.1.1.1. Powder
        • 7.2.6.1.1.2. Liquid
        • 7.2.6.1.1.3. Encapsulated
        • 7.2.6.1.1.4. Others
    • 7.2.6.2. U.K.
      • 7.2.6.2.1. By Form (Value)
        • 7.2.6.2.1.1. Powder
        • 7.2.6.2.1.2. Liquid
        • 7.2.6.2.1.3. Encapsulated
        • 7.2.6.2.1.4. Others
    • 7.2.6.3. France
      • 7.2.6.3.1. By Form (Value)
        • 7.2.6.3.1.1. Powder
        • 7.2.6.3.1.2. Liquid
        • 7.2.6.3.1.3. Encapsulated
        • 7.2.6.3.1.4. Others
    • 7.2.6.4. Italy
      • 7.2.6.4.1. By Form (Value)
        • 7.2.6.4.1.1. Powder
        • 7.2.6.4.1.2. Liquid
        • 7.2.6.4.1.3. Encapsulated
        • 7.2.6.4.1.4. Others
    • 7.2.6.5. Spain
      • 7.2.6.5.1. By Form (Value)
        • 7.2.6.5.1.1. Powder
        • 7.2.6.5.1.2. Liquid
        • 7.2.6.5.1.3. Encapsulated
        • 7.2.6.5.1.4. Others
    • 7.2.6.6. Rest of Europe
      • 7.2.6.6.1. By Form (Value)
        • 7.2.6.6.1.1. Powder
        • 7.2.6.6.1.2. Liquid
        • 7.2.6.6.1.3. Encapsulated
        • 7.2.6.6.1.4. Others

8. Asia Pacific Probiotics Market Analysis, Insights and Forecast, 2026-2034

• 8.1. Key Findings / Summary
  • 8.1.1. By Product Type (Value)
    • 8.1.1.1. Food and Beverages
      • 8.1.1.1.1. Dairy-based products
      • 8.1.1.1.2. Non-dairy based beverages
      • 8.1.1.1.3. Cereals & snacks
      • 8.1.1.1.4. Baked food
      • 8.1.1.1.5. Frozen & confectionery
      • 8.1.1.1.6. Ready-to-eat packaged meals
    • 8.1.1.2. Supplements
      • 8.1.1.2.1. Nutritional supplements
      • 8.1.1.2.2. Specialty supplements
      • 8.1.1.2.3. Infant formula
    • 8.1.1.3. Animal Feed
    • 8.1.1.4. Cosmetics
  • 8.1.2. By Source (Value)
    • 8.1.2.1. Bacteria
      • 8.1.2.1.1. Lactobacillus
      • 8.1.2.1.2. Bifidobacterium
      • 8.1.2.1.3. Others
    • 8.1.2.2. Yeast
    • 8.1.2.3. Others
  • 8.1.3. By Form (Value)
    • 8.1.3.1. Powder
      • 8.1.3.1.1. Liquid
      • 8.1.3.1.2. Encapsulated
      • 8.1.3.1.3. Others
  • 8.1.4. By End Use (Value)
    • 8.1.4.1. Human
      • 8.1.4.1.1. Animal
  • 8.1.5. By Distribution Channel (Value)
    • 8.1.5.1. Supermarkets & Hypermarkets
      • 8.1.5.1.1. Pharmacies & Drug Stores
      • 8.1.5.1.2. Health & Specialty Stores
      • 8.1.5.1.3. Online Retail / E-commerce
      • 8.1.5.1.4. Others
  • 8.1.6. By Country
    • 8.1.6.1. China
      • 8.1.6.1.1. By Form (Value)
        • 8.1.6.1.1.1. Powder
        • 8.1.6.1.1.2. Liquid
        • 8.1.6.1.1.3. Encapsulated
        • 8.1.6.1.1.4. Others
    • 8.1.6.2. India
      • 8.1.6.2.1. By Form (Value)
        • 8.1.6.2.1.1. Powder
        • 8.1.6.2.1.2. Liquid
        • 8.1.6.2.1.3. Encapsulated
        • 8.1.6.2.1.4. Others
    • 8.1.6.3. Japan
      • 8.1.6.3.1. By Form (Value)
        • 8.1.6.3.1.1. Powder
        • 8.1.6.3.1.2. Liquid
        • 8.1.6.3.1.3. Encapsulated
        • 8.1.6.3.1.4. Others
    • 8.1.6.4. Southeast Asia
      • 8.1.6.4.1. By Form (Value)
        • 8.1.6.4.1.1. Powder
        • 8.1.6.4.1.2. Liquid
        • 8.1.6.4.1.3. Encapsulated
        • 8.1.6.4.1.4. Others
    • 8.1.6.5. Australia
      • 8.1.6.5.1. By Form (Value)
        • 8.1.6.5.1.1. Powder
        • 8.1.6.5.1.2. Liquid
        • 8.1.6.5.1.3. Encapsulated
        • 8.1.6.5.1.4. Others
    • 8.1.6.6. Rest of Asia Pacific
      • 8.1.6.6.1. By Form (Value)
        • 8.1.6.6.1.1. Powder
        • 8.1.6.6.1.2. Liquid
        • 8.1.6.6.1.3. Encapsulated
        • 8.1.6.6.1.4. Others

9. South America Probiotics Market Analysis, Insights and Forecast, 2026-2034

• 9.1. By Product Type (Value)
  • 9.1.1. Food and Beverages
    • 9.1.1.1. Dairy-based products
      • 9.1.1.1.1. Non-dairy based beverages
      • 9.1.1.1.2. Cereals & snacks
      • 9.1.1.1.3. Baked food
      • 9.1.1.1.4. Frozen & confectionery
      • 9.1.1.1.5. Ready-to-eat packaged meals
    • 9.1.1.2. Supplements
      • 9.1.1.2.1. Nutritional supplements
      • 9.1.1.2.2. Specialty supplements
      • 9.1.1.2.3. Infant formula
    • 9.1.1.3. Animal Feed
    • 9.1.1.4. Cosmetics
  • 9.1.2. By Source (Value)
    • 9.1.2.1. Bacteria
      • 9.1.2.1.1. Lactobacillus
      • 9.1.2.1.2. Bifidobacterium
      • 9.1.2.1.3. Others
    • 9.1.2.2. Yeast
    • 9.1.2.3. Others
  • 9.1.3. By Form (Value)
    • 9.1.3.1. Powder
      • 9.1.3.1.1. Liquid
      • 9.1.3.1.2. Encapsulated
      • 9.1.3.1.3. Others
  • 9.1.4. By End Use (Value)
    • 9.1.4.1. Human
      • 9.1.4.1.1. Animal
  • 9.1.5. By Distribution Channel (Value)
    • 9.1.5.1. Supermarkets & Hypermarkets
      • 9.1.5.1.1. Pharmacies & Drug Stores
      • 9.1.5.1.2. Health & Specialty Stores
      • 9.1.5.1.3. Online Retail / E-commerce
      • 9.1.5.1.4. Others
  • 9.1.6. By Country
    • 9.1.6.1. Brazil
      • 9.1.6.1.1. By Form (Value)
        • 9.1.6.1.1.1. Powder
        • 9.1.6.1.1.2. Liquid
        • 9.1.6.1.1.3. Encapsulated
        • 9.1.6.1.1.4. Others
    • 9.1.6.2. Argentina
      • 9.1.6.2.1. By Form (Value)
        • 9.1.6.2.1.1. Powder
        • 9.1.6.2.1.2. Liquid
        • 9.1.6.2.1.3. Encapsulated
        • 9.1.6.2.1.4. Others
    • 9.1.6.3. Rest of South America
      • 9.1.6.3.1. By Form (Value)
        • 9.1.6.3.1.1. Powder
        • 9.1.6.3.1.2. Liquid
        • 9.1.6.3.1.3. Encapsulated
        • 9.1.6.3.1.4. Others

10. Middle East & Africa Probiotics Market Analysis, Insights and Forecast, 2026-2034

• 10.1. Key Findings / Summary
  • 10.1.1. By Product Type (Value)
    • 10.1.1.1. Food and Beverages
      • 10.1.1.1.1. Dairy-based products
      • 10.1.1.1.2. Non-dairy based beverages
      • 10.1.1.1.3. Cereals & snacks
      • 10.1.1.1.4. Baked food
      • 10.1.1.1.5. Frozen & confectionery
      • 10.1.1.1.6. Ready-to-eat packaged meals
    • 10.1.1.2. Supplements
      • 10.1.1.2.1. Nutritional supplements
      • 10.1.1.2.2. Specialty supplements
      • 10.1.1.2.3. Infant formula
    • 10.1.1.3. Animal Feed
    • 10.1.1.4. Cosmetics
  • 10.1.2. By Source (Value)
    • 10.1.2.1. Bacteria
      • 10.1.2.1.1. Lactobacillus
      • 10.1.2.1.2. Bifidobacterium
      • 10.1.2.1.3. Others
    • 10.1.2.2. Yeast
    • 10.1.2.3. Others
  • 10.1.3. By Form (Value)
    • 10.1.3.1. Powder
      • 10.1.3.1.1. Liquid
      • 10.1.3.1.2. Encapsulated
      • 10.1.3.1.3. Others
  • 10.1.4. By End Use (Value)
    • 10.1.4.1. Human
      • 10.1.4.1.1. Animal
  • 10.1.5. By Distribution Channel (Value)
    • 10.1.5.1. Supermarkets & Hypermarkets
      • 10.1.5.1.1. Pharmacies & Drug Stores
      • 10.1.5.1.2. Health & Specialty Stores
      • 10.1.5.1.3. Online Retail / E-commerce
      • 10.1.5.1.4. Others
  • 10.1.6. By Country
    • 10.1.6.1. UAE
      • 10.1.6.1.1. By Form (Value)
        • 10.1.6.1.1.1. Powder
        • 10.1.6.1.1.2. Liquid
        • 10.1.6.1.1.3. Encapsulated
        • 10.1.6.1.1.4. Others
    • 10.1.6.2. South Africa
      • 10.1.6.2.1. By Form (Value)
        • 10.1.6.2.1.1. Powder
        • 10.1.6.2.1.2. Liquid
        • 10.1.6.2.1.3. Encapsulated
        • 10.1.6.2.1.4. Others
    • 10.1.6.3. Rest of MEA
      • 10.1.6.3.1. By Form (Value)
        • 10.1.6.3.1.1. Powder
        • 10.1.6.3.1.2. Liquid
        • 10.1.6.3.1.3. Encapsulated
        • 10.1.6.3.1.4. Others

11. Competitive Matrix

• 11.1. Business Strategies Adopted by Leading Players
• 11.2. Global Probiotics Market Revenue Share/Ranking Analysis, By Key Manufacturer, 2025

12. Company Profiles

• 12.1. Yakult Honsha Co., Ltd.
  • 12.1.1. Overview
  • 12.1.2. Description
  • 12.1.3. Type Portfolio
  • 12.1.4. Financials (Data as available in public domain and/or on paid databases)
  • 12.1.5. Recent Developments

13. Similar in information has been provided for all the below companies

• 13.1. Danone S.A.
• 13.2. Nestle S.A.
• 13.3. Chr. Hansen Holding A/S
• 13.4. DuPont Nutritona dn Biosciences
• 13.5. BioGaia AB
• 13.6. Probi AB
• 13.7. ADM
• 13.8. Kerry Group Plc
• 13.9. Meiji Holdings Co., Ltd.

14. Strategic Recommendations

15. Appendix